(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. HH signaling to the cardiomyoblast and pericyte is essential for
coronary development. (A,B) Whole-mount PECAM
immunohistochemistry demonstrating that, compared with control (A),
Smomlc2v; dermo1 CKO heart (B) displays an arrest in
coronary development. Bracket indicates atrial ventricular groove. (C)
β-Galactosidase staining of an E12.5 Mlc2v-Cre/Rosa26R heart,
demonstrating that Mlc2v-Cre does not efficiently target
cardiomyoblasts located in the atrial ventricular grove (AVG, bracket). By
contrast, Mlv2v-Cre efficiently targets the ventricular myocardium
(area below bracket). (D,E) Cryosections of hearts stained with
in situ probes for Ptch1 revealing that, compared with controls (D),
Smomlc2v; dermo1 CKO hearts (E) lack both myocardial
(asterisk) and perivascular (arrow) sources of Ptch1 expression.
(F-K) Immunofluorescent staining of cryosections for PECAM (red) and
VEGF ligands (green) reveal that, compared with controls (F,H,J),
Smomlc2v; dermo1 CKO hearts (G,I,K) display diminished
expression of VEGFA (F,G), VEGFB (H,I) and VEGFC (J,K). White arrowhead
indicates (PECAM-positive) endocardial cells that appear unaffected in these
conditional mutants. Red arrow in A,D denotes orientation of tissue sections
in relation to whole-mount photographs (B, base; A, apex).